How much funding has Serapha Bio raised?

Serapha Bio has raised $138.0M in total funding, most recently a series a round.

Who are Serapha Bio's investors?

Serapha Bio's investors include RA Capital Management, RTW Investments.

When was Serapha Bio founded?

Serapha Bio was founded in 2026.

Where is Serapha Bio headquartered?

Serapha Bio is headquartered in San Diego, California, United States.

What industry is Serapha Bio in?

Serapha Bio operates in Biotech, Healthcare.

How many employees does Serapha Bio have?

Serapha Bio has 1-10 employees.

Serapha Bio

San Diego, United States · Founded 2026 · $138.0M raised

Biotech

Healthcare

Headquarters: San Diego, California
Employees: 1–10
Founded: 2026
Business Model: B2B

Website: seraphabio.com
Total Funding: $138.0M
Last Round: $138.0M Series AJun 2026
Rounds: 1

About

Serapha Bio is a gene-editing company developing treatments for alpha-1 antitrypsin deficiency (AATD) and other genetic diseases. The company has raised $138M and is advancing its pipeline through a merger with Boundless Bio alongside a $230M private placement.

Summary

Serapha Bio is a Biotech company based in San Diego, United States, founded in 2026. It has raised $138.0M in total across 1 round, most recently a $138.0M Series A round in Jun 2026. Investors include RA Capital Management and RTW Investments.